MX2022014634A - Metodos para la administracion linfatica de agentes activos. - Google Patents

Metodos para la administracion linfatica de agentes activos.

Info

Publication number
MX2022014634A
MX2022014634A MX2022014634A MX2022014634A MX2022014634A MX 2022014634 A MX2022014634 A MX 2022014634A MX 2022014634 A MX2022014634 A MX 2022014634A MX 2022014634 A MX2022014634 A MX 2022014634A MX 2022014634 A MX2022014634 A MX 2022014634A
Authority
MX
Mexico
Prior art keywords
methods
active agents
lymphatic delivery
agents
delivery
Prior art date
Application number
MX2022014634A
Other languages
English (en)
Inventor
Russell Frederick Ross
Original Assignee
Sorrento Therapeutics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sorrento Therapeutics Inc filed Critical Sorrento Therapeutics Inc
Publication of MX2022014634A publication Critical patent/MX2022014634A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M37/00—Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M37/00—Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin
    • A61M37/0015—Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin by using microneedles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M37/00—Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin
    • A61M2037/0007—Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin having means for enhancing the permeation of substances through the epidermis, e.g. using suction or depression, electric or magnetic fields, sound waves or chemical agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M37/00—Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin
    • A61M37/0015—Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin by using microneedles
    • A61M2037/0023—Drug applicators using microneedles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M37/00—Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin
    • A61M37/0015—Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin by using microneedles
    • A61M2037/003—Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin by using microneedles having a lumen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M37/00—Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin
    • A61M37/0015—Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin by using microneedles
    • A61M2037/0038—Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin by using microneedles having a channel at the side surface
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M37/00—Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin
    • A61M37/0015—Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin by using microneedles
    • A61M2037/0061—Methods for using microneedles

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Dermatology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Hematology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Biomedical Technology (AREA)
  • Anesthesiology (AREA)
  • Medical Informatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Media Introduction/Drainage Providing Device (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Cosmetics (AREA)
  • Infusion, Injection, And Reservoir Apparatuses (AREA)

Abstract

La presente invención se refiere a la administración de agentes a la piel. Los métodos para administrar agentes tales como agentes bioactivos se contemplan en la presente invención. Específicamente, se describen métodos para administrar un agente a una o más áreas de la epidermis y, de esta manera, al sistema linfático.
MX2022014634A 2015-07-24 2018-01-08 Metodos para la administracion linfatica de agentes activos. MX2022014634A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201562196568P 2015-07-24 2015-07-24
US201562196558P 2015-07-24 2015-07-24

Publications (1)

Publication Number Publication Date
MX2022014634A true MX2022014634A (es) 2023-01-18

Family

ID=57885089

Family Applications (2)

Application Number Title Priority Date Filing Date
MX2018000126A MX2018000126A (es) 2015-07-24 2016-07-22 Metodos para la administracion linfatica de agentes activos.
MX2022014634A MX2022014634A (es) 2015-07-24 2018-01-08 Metodos para la administracion linfatica de agentes activos.

Family Applications Before (1)

Application Number Title Priority Date Filing Date
MX2018000126A MX2018000126A (es) 2015-07-24 2016-07-22 Metodos para la administracion linfatica de agentes activos.

Country Status (15)

Country Link
US (3) US10737082B2 (es)
EP (2) EP3325081B1 (es)
JP (3) JP6929829B2 (es)
KR (1) KR20180035210A (es)
CN (1) CN107949418B (es)
AU (3) AU2016297832B2 (es)
BR (1) BR112018001435A2 (es)
CA (1) CA2991459A1 (es)
DK (1) DK3325081T3 (es)
ES (1) ES2893673T3 (es)
HU (1) HUE056424T2 (es)
MX (2) MX2018000126A (es)
PL (1) PL3325081T3 (es)
RU (1) RU2719946C2 (es)
WO (1) WO2017019535A2 (es)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK3325080T3 (da) * 2015-07-24 2021-10-04 Sorrento Therapeutics Inc Fremgangsmåder til bedre indgivelse af aktive midler til tumorer
JP6929829B2 (ja) * 2015-07-24 2021-09-01 ソレント・セラピューティクス・インコーポレイテッド 薬剤送達装置
US20200206352A1 (en) * 2017-08-31 2020-07-02 Tohoku University Optimal osmotic range for a drug-containing solution suitable for lymphatic delivery
IL293479A (en) 2019-12-05 2022-08-01 Sorrento Therapeutics Inc Method of treating cancer by administration of an anti-pd-1 or anti-pd-l1 therapeutic agent via a lymphatic delivery device
JP7509402B2 (ja) * 2020-02-26 2024-07-02 国立大学法人 和歌山大学 解析装置、センシングシステム、解析装置の動作方法、及び、コンピュータプログラム
WO2022159736A1 (en) 2021-01-22 2022-07-28 Sorrento Therapeutics, Inc. Device for microliter-scale lymphatic delivery of coronavirus vaccines
WO2022192594A2 (en) 2021-03-11 2022-09-15 Sorrento Therapeutics, Inc. Nucleic acid molecules and vaccines comprising same for the prevention and treatment of coronavirus infections and disease
CN117916264A (zh) 2021-06-09 2024-04-19 索伦托药业有限公司 通过经由淋巴微针递送装置施用抗pd-1或抗pd-l1治疗剂来治疗癌症的方法
CN113368385A (zh) * 2021-06-21 2021-09-10 温州医科大学慈溪生物医药研究院 利用淋巴通路递送生物大分子药物入脑的输送系统
KR20240056524A (ko) 2021-08-18 2024-04-30 소렌토 쎄라퓨틱스, 인코포레이티드 림프계를 표적화하는 치료학적 제제
WO2025129128A1 (en) 2023-12-15 2025-06-19 Vivasor, Inc. Compositions and methods for non-viral delivery of therapeutic compounds

Family Cites Families (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IE72524B1 (en) 1994-11-04 1997-04-23 Elan Med Tech Analyte-controlled liquid delivery device and analyte monitor
US6503231B1 (en) * 1998-06-10 2003-01-07 Georgia Tech Research Corporation Microneedle device for transport of molecules across tissue
US20020095134A1 (en) 1999-10-14 2002-07-18 Pettis Ronald J. Method for altering drug pharmacokinetics based on medical delivery platform
ATE253910T1 (de) * 2000-06-01 2003-11-15 Watson Pharmaceuticals Inc Transdermale verabreichung von lasofoxifen
ES2393282T3 (es) * 2001-09-12 2012-12-20 Becton, Dickinson And Company Dispositivo de pluma basado en microaguja para la administración de fármacos
JP2006516006A (ja) 2003-01-16 2006-06-15 ベクトン・ディキンソン・アンド・カンパニー 細ゲージのマイクロカニューレを用いる皮内細胞の送達
AU2004264839B2 (en) 2003-06-13 2009-06-04 Becton, Dickinson And Company Improved intra-dermal delivery of biologically active agents
BRPI0414014A (pt) 2003-08-26 2006-10-24 Becton Dickinson Co métodos para distribuição intradérmica de agentes terapêuticos
WO2006127962A2 (en) 2005-05-25 2006-11-30 Becton, Dickinson And Comapny Particulate formulations for intradermal delivery of biologically active agents
CA2618807C (en) 2005-08-12 2015-01-06 University Health Network Methods and devices for lymphatic targeting
WO2007047539A2 (en) 2005-10-14 2007-04-26 Medtronic, Inc. Localized delivery to the lymphatic system
US8197435B2 (en) * 2006-05-02 2012-06-12 Emory University Methods and devices for drug delivery to ocular tissue using microneedle
WO2008038140A2 (en) 2006-06-07 2008-04-03 Foamix Ltd. Foamable vehicle comprising polypropylene glycol alkyl ether and pharmaceutical compositions thereof
EP2100850A1 (en) * 2008-03-11 2009-09-16 Stichting Voor De Technische Wetenschappen Microneedle array and a method for manufacturing microneedles
US9040087B2 (en) * 2008-10-31 2015-05-26 The Invention Science Fund I, Llc Frozen compositions and methods for piercing a substrate
RU2570280C2 (ru) 2010-04-28 2015-12-10 Кимберли-Кларк Ворлдвайд, Инк. Композитная матрица микроигл, содержащая на поверхности наноструктуры
WO2012046149A1 (en) * 2010-04-28 2012-04-12 Kimberly-Clark Worldwide, Inc. Method for increasing permeability of an epithelial barrier
PT2563450T (pt) 2010-04-28 2017-08-28 Kimberly Clark Co Dispositivo para entrega de medicação para a artrite reumatóide
US9522262B2 (en) 2010-04-28 2016-12-20 Kimberly-Clark Worldwide, Inc. Medical devices for delivery of siRNA
US20120187814A1 (en) 2011-01-25 2012-07-26 Fryling Nicholas A Furniture System and a Frame Assembly for a Furniture System
US20120245445A1 (en) * 2011-03-21 2012-09-27 Michael Darryl Black Glucose Monitoring System
RU2656156C2 (ru) * 2011-10-17 2018-05-31 Массачусетс Инститьют Оф Текнолоджи Внутриклеточная доставка
CN104039382B (zh) * 2011-10-27 2018-01-12 金伯利-克拉克环球有限公司 高粘度生物活性剂的经皮递送
US20170246439A9 (en) 2011-10-27 2017-08-31 Kimberly-Clark Worldwide, Inc. Increased Bioavailability of Transdermally Delivered Agents
CN112933391A (zh) * 2012-05-01 2021-06-11 高等教育联邦系统-匹兹堡大学 用于经皮插入的尖端负载的微针阵列
KR102370538B1 (ko) 2013-02-28 2022-03-07 소렌토 쎄라퓨틱스, 인코포레이티드 경피 약물 전달 장치
WO2014132239A1 (en) 2013-02-28 2014-09-04 Kimberly-Clark Worldwide, Inc. Drug delivery device
JP2016517762A (ja) 2013-05-23 2016-06-20 キンバリー クラーク ワールドワイド インコーポレイテッド 開放チャネル断面形状が改善されたマイクロニードル
JP6929829B2 (ja) * 2015-07-24 2021-09-01 ソレント・セラピューティクス・インコーポレイテッド 薬剤送達装置
DK3325080T3 (da) * 2015-07-24 2021-10-04 Sorrento Therapeutics Inc Fremgangsmåder til bedre indgivelse af aktive midler til tumorer

Also Published As

Publication number Publication date
ES2893673T3 (es) 2022-02-09
KR20180035210A (ko) 2018-04-05
EP3325081B1 (en) 2021-09-08
BR112018001435A2 (pt) 2018-09-11
EP3325081A2 (en) 2018-05-30
AU2020233748A1 (en) 2020-10-08
CN107949418A (zh) 2018-04-20
JP2021185160A (ja) 2021-12-09
CN107949418B (zh) 2024-07-02
US20200338329A1 (en) 2020-10-29
HUE056424T2 (hu) 2022-02-28
WO2017019535A2 (en) 2017-02-02
RU2018104104A3 (es) 2019-10-31
US20180193625A1 (en) 2018-07-12
MX2018000126A (es) 2018-03-23
DK3325081T3 (da) 2021-10-11
US20240181235A1 (en) 2024-06-06
JP6929829B2 (ja) 2021-09-01
AU2016297832B2 (en) 2020-07-16
RU2018104104A (ru) 2019-08-26
CA2991459A1 (en) 2017-02-02
AU2020233748B2 (en) 2022-08-25
EP3922238A1 (en) 2021-12-15
PL3325081T3 (pl) 2021-12-20
AU2016297832A1 (en) 2018-02-15
RU2719946C2 (ru) 2020-04-23
AU2022275393A1 (en) 2023-01-05
JP2018522002A (ja) 2018-08-09
JP2023015135A (ja) 2023-01-31
EP3325081A4 (en) 2019-04-10
JP7167272B2 (ja) 2022-11-08
US10737082B2 (en) 2020-08-11

Similar Documents

Publication Publication Date Title
MX2022014634A (es) Metodos para la administracion linfatica de agentes activos.
MA40437A (fr) Méthodes de traitement du cancer faisant appel à des inhibiteurs de tigit et à des agents anticancéreux
EP4421094A3 (en) Targeted therapeutic agents and uses thereof
MX2018008190A (es) Sistemas y metodos para la administracion transdermica a largo plazo.
ZA201603342B (en) Combination therapy including an mdm2 inhibitor and one or more additional pharmaceutically active agents for the treatment of cancers
MY195009A (en) Cellular Targeted Active Ingredient Delivery System
GB2541571A (en) Pharmaceutical compositions
MX2022014277A (es) Metodos para una mejor administracion de agentes activos a tumores.
PH12019502002A1 (en) Combination theraphy
PH12018501279A1 (en) Compositions comprising 15-hepe and methods of using the same
BR112018000217A2 (pt) sistemas de distribuição de nanopartículas aperfeiçoados
PH12016501527B1 (en) Pharmaceutical composition comprising diamino heterocyclic carboxamide compound as active ingredient
MX2016007445A (es) Inhibidores de f1f0-atpasa de trifluorometil pirazolil guanidina y usos terapeuticos de los mismos.
MX2020003762A (es) Composiciones cosmeticas y metodo para tratar la piel.
MX395492B (es) Usos terapeuticos de l-4 cloroquinurenina.
MX2022011564A (es) Tratamiento del dolor.
SG10201902499VA (en) Therapeutic nanoparticles and related compositions, methods and systems
MX2016005614A (es) Cuerpos de inclusion para el suministro transdermico de agentes terapeuticos y cosmeticos.
MX373177B (es) Métodos de tratamiento de disquinesia y trastornos relacionados.
NZ746011A (en) Glycoalkaloid combinations and various uses thereof
PH12019502145A1 (en) Agent for preventing myopia, treating myopia, and/or preventing myopia progression comprising tiotropium as active ingredient
MA40642A (fr) Nouveaux dérivés peptidiques et leurs utilisations
PH12018500339A1 (en) Lysobactin for use in the treatment of bovine mastitis
MX2018000418A (es) Derivados de amida que tienen actividad multimodal contra el dolor.
NZ725354A (en) Transdermal formulations of pergolide and uses thereof